Drug Patent Expirations in April 2014

Drug Patent Expirations in April 2014

Drug Patent Expirations for April 2014

Tradename Applicant Generic Name Patent Number Patent Expiration
MAXALT-MLT Merck rizatriptan benzoate 5,457,895*PED Apr 1, 2014
FROVA Endo Pharms frovatriptan succinate 5,616,603 Apr 1, 2014
ABELCET Sigma Tau amphotericin b 5,616,334 Apr 1, 2014
BROVANA Sunovion arformoterol tartrate 6,589,508 Apr 3, 2014
INCRELEX Ipsen Inc mecasermin recombinant 6,207,640 Apr 7, 2014
VIRACEPT Agouron nelfinavir mesylate 5,952,343*PED Apr 7, 2014
NIZORAL A-D Mcneil Cons ketoconazole 5,456,851 Apr 7, 2014
VIRACEPT Agouron nelfinavir mesylate 5,484,926*PED Apr 7, 2014
VIRACEPT Agouron nelfinavir mesylate 6,162,812*PED Apr 7, 2014
INVEGA SUSTENNA Janssen Pharms paliperidone palmitate 5,254,556*PED Apr 15, 2014
ATELVIA Warner Chilcott Llc risedronate sodium 5,622,721 Apr 21, 2014
ALREX Bausch And Lomb loteprednol etabonate 5,540,930*PED Apr 25, 2014
LOTEMAX Bausch And Lomb loteprednol etabonate 5,540,930*PED Apr 25, 2014
ZYLET Bausch And Lomb loteprednol etabonate; tobramycin 5,540,930*PED Apr 25, 2014
ALREX Bausch And Lomb loteprednol etabonate 5,747,061*PED Apr 25, 2014
LOTEMAX Bausch And Lomb loteprednol etabonate 5,747,061*PED Apr 25, 2014
ZYLET Bausch And Lomb loteprednol etabonate; tobramycin 5,747,061*PED Apr 25, 2014
ABREVA Glaxosmithkline docosanol 4,874,794 Apr 28, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.